IMMUNOPRECISE ANTIBOD. earnings per share and revenue

TQB earnings per share for the last quarter are -0.10 EUR whereas the estimation was -0.07 EUR which accounts for -36.36% surprise. Company revenue for the same period amounts to 3.55 M EUR despite the estimated figure of 4.52 M EUR. Estimated earnings per share for the next quarter are -0.06 EUR, and revenue is expected to reach 4.24 M EUR. Also watch annual changes over time to get a bigger picture of TQB earnings per share and revenue dynamics.